SCHEMBL3664698

SCHEMBL3664698

COC(=O)C1CCCN(c2ncc(Br)cn2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.50
HPGD P15428 3/20 0.50
LMNA P02545 3/20 0.48
RAB9A P51151 3/20 0.48
NPC1 O15118 2/20 0.48
CTSL P07711 1/20 0.48
CTSS P25774 1/20 0.48
HSD17B10 Q99714 3/20 0.46
TSHR P16473 3/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
ALDH1A1 P00352 3/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP2C19 P33261 1/20 0.43
ACACB O00763 1/20 0.43
POLB P06746 1/20 0.43
OPRK1 P41145 1/20 0.42
GPBAR1 Q8TDU6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20474703 0.86 ACACB (0.47) KDM4EALDH1A1ACACBOPRK1
SCHEMBL3666825 0.83 KDM4E (0.57) KDM4EHPGDLMNACTSLCTSS
SCHEMBL3885440 0.83 KDM4E (0.58) KDM4EHPGDLMNARAB9ANPC1
SCHEMBL5842028 0.83 KDM4E (0.58) KDM4EHPGDLMNARAB9ANPC1
SCHEMBL3659822 0.79 KDM4E (0.43) KDM4EHPGDLMNARAB9ANPC1
SCHEMBL20446031 0.77 HSD17B10 (0.43) KDM4ELMNAHSD17B10TSHRGAA
SCHEMBL20507605 0.76 DGAT2 (0.44) ACACB
SCHEMBL25447234 0.75 ACACB (0.39) KDM4EHPGDHSD17B10TSHRALDH1A1
SCHEMBL10174359 0.74 KMT2A (0.47) KDM4ERAB9ANPC1MEN1KMT2A
SCHEMBL3452628 0.74 NOTUM (0.45) KDM4ETSHRMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231653-B1 ANTIBACTERIAL CONDENSED THIAZOLES BIOTA EUROPE LTD (GB) 2013-04-03 EP disclosed
US-8299065-B2 Antibacterial condensed thiazoles BIOTA EUROPE LTD. (GB) 2012-10-30 US disclosed
US-20100305067-A1 ANTIBACTERIAL CONDENSED THIAZOLES BIOTA EUROPE LTD (GB) 2010-12-02 US disclosed
EP-2231653-A1 ANTIBACTERIAL CONDENSED THIAZOLES Biota Europe Ltd (GB) 2010-09-29 EP disclosed
WO-2009074812-A1 ANTIBACTERIAL CONDENSED THIAZOLES PROLYSIS LTD (GB) 2009-06-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305067-A1 ANTIBACTERIAL CONDENSED THIAZOLES NEK6, NEK1, TXK KDM4E 3573/4885HPGD 3728/4885LMNA 2928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.